chr1-22086536-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_001791.4(CDC42):c.276C>T(p.Asn92Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,607,852 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00089 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 5 hom. )
Consequence
CDC42
NM_001791.4 synonymous
NM_001791.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.41
Genes affected
CDC42 (HGNC:1736): (cell division cycle 42) The protein encoded by this gene is a small GTPase of the Rho-subfamily, which regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. This protein is highly similar to Saccharomyces cerevisiae Cdc 42, and is able to complement the yeast cdc42-1 mutant. The product of oncogene Dbl was reported to specifically catalyze the dissociation of GDP from this protein. This protein could regulate actin polymerization through its direct binding to Neural Wiskott-Aldrich syndrome protein (N-WASP), which subsequently activates Arp2/3 complex. Alternative splicing of this gene results in multiple transcript variants. Pseudogenes of this gene have been identified on chromosomes 3, 4, 5, 7, 8 and 20. [provided by RefSeq, Apr 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 1-22086536-C-T is Benign according to our data. Variant chr1-22086536-C-T is described in ClinVar as [Benign]. Clinvar id is 730778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.41 with no splicing effect.
BS2
High AC in GnomAd4 at 135 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDC42 | NM_001791.4 | c.276C>T | p.Asn92Asn | synonymous_variant | Exon 4 of 6 | ENST00000656825.1 | NP_001782.1 | |
CDC42 | NM_001039802.2 | c.276C>T | p.Asn92Asn | synonymous_variant | Exon 5 of 7 | NP_001034891.1 | ||
CDC42 | NM_044472.3 | c.276C>T | p.Asn92Asn | synonymous_variant | Exon 4 of 6 | NP_426359.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000875 AC: 133AN: 152086Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
133
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00121 AC: 301AN: 249510Hom.: 0 AF XY: 0.00121 AC XY: 163AN XY: 135046
GnomAD3 exomes
AF:
AC:
301
AN:
249510
Hom.:
AF XY:
AC XY:
163
AN XY:
135046
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00147 AC: 2143AN: 1455648Hom.: 5 Cov.: 29 AF XY: 0.00148 AC XY: 1071AN XY: 723608
GnomAD4 exome
AF:
AC:
2143
AN:
1455648
Hom.:
Cov.:
29
AF XY:
AC XY:
1071
AN XY:
723608
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000887 AC: 135AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.000739 AC XY: 55AN XY: 74404
GnomAD4 genome
AF:
AC:
135
AN:
152204
Hom.:
Cov.:
32
AF XY:
AC XY:
55
AN XY:
74404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
CDC42: BS1, BS2 -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at